270 related articles for article (PubMed ID: 14632210)
21. Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.
Ashktorab H; Smoot DT; Farzanmehr H; Fidelia-Lambert M; Momen B; Hylind L; Iacosozio-Dononue C; Carethers JM; Goel A; Boland CR; Giardiello FM
Int J Cancer; 2005 Oct; 116(6):914-9. PubMed ID: 15856472
[TBL] [Abstract][Full Text] [Related]
22. Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Sakamoto A; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2003 Sep; 34(9):841-9. PubMed ID: 14562278
[TBL] [Abstract][Full Text] [Related]
23. Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability.
Baek MJ; Kang H; Kim SE; Park JH; Lee JS; Paik YK; Kim H
Br J Cancer; 2001 Oct; 85(8):1147-52. PubMed ID: 11710827
[TBL] [Abstract][Full Text] [Related]
24. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
26. Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability.
Murata H; Khattar NH; Kang Y; Gu L; Li GM
Oncogene; 2002 Aug; 21(37):5696-703. PubMed ID: 12173039
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
[TBL] [Abstract][Full Text] [Related]
28. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability in gastric cancer is closely associated with hMLH1 hypermethylation at the proximal region of the promoter.
Ishiguro K; Kawakami K; Maeda K; Ishida Y; Omura K; Watanabe G
Int J Mol Med; 2003 Oct; 12(4):603-8. PubMed ID: 12964042
[TBL] [Abstract][Full Text] [Related]
30. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.
Cai KQ; Albarracin C; Rosen D; Zhong R; Zheng W; Luthra R; Broaddus R; Liu J
Hum Pathol; 2004 May; 35(5):552-9. PubMed ID: 15138928
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology.
Parc YR; Halling KC; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN; Halling AC
Int J Cancer; 2000 Apr; 86(1):60-6. PubMed ID: 10728595
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.
Peiró G; Diebold J; Lohse P; Ruebsamen H; Lohse P; Baretton GB; Löhrs U
Hum Pathol; 2002 Mar; 33(3):347-54. PubMed ID: 11979377
[TBL] [Abstract][Full Text] [Related]
34. Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteria.
Kim JC; Lee KH; Ka IH; Koo KH; Roh SA; Kim HC; Yu CS; Kim TW; Chang HM; Gong GY; Kim JS
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6159-68. PubMed ID: 15448003
[TBL] [Abstract][Full Text] [Related]
35. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening.
Potocnik U; Glavac D; Golouh R; Ravnik-Glavac M
Cancer Genet Cytogenet; 2001 Apr; 126(2):85-96. PubMed ID: 11376800
[TBL] [Abstract][Full Text] [Related]
36. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa.
Guo RJ; Arai H; Kitayama Y; Igarashi H; Hemmi H; Arai T; Hanai H; Sugimura H
Pathol Int; 2001 Apr; 51(4):240-7. PubMed ID: 11350605
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.
Arnold CN; Goel A; Compton C; Marcus V; Niedzwiecki D; Dowell JM; Wasserman L; Inoue T; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Jan; 3(1):73-8. PubMed ID: 14726676
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of hMSH2 and hMLH1 in colorectal cancer patients in India.
Rajkumar T; Soumittra N; Pandey D; Nancy KN; Mahajan V; Majhi U
Genet Test; 2004; 8(2):157-62. PubMed ID: 15345113
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
